HOPA Member Awards

The HOPA Award of Excellence recognizes a member who has made a significant, sustained contribution to or provided excellent leadership in improving or supporting hematology/oncology pharmacy.

The award was created to honor Phil Johnson from the H. Lee Moffitt Cancer Center & Research Institute, who unselfishly allowed HOPA to adopt the Making a Difference in Oncology conference as the HOPA Annual Conference

Award: Recipients of the award receive a lifetime HOPA membership and are recognized at the HOPA Annual Conference with a personalized plaque and an award check. In return, award winners are asked to make a short presentation about their contributions to hematology/oncology pharmacy.

Eligibility: Nominees and nominator(s) must be HOPA members in good standing. Current members of the HOPA Board of Directors or HOPA Recognition Committee are not eligible to nominate an individual for this award nor are they eligible to be nominated for this award. Previous recipients of the Award of Excellence are not eligible to be nominated for this award.

The HOPA Access, Representation, and Opportunity (ARO) Award recognizes pharmacy practitioners who have demonstrated a commitment to improving ARO within HOPA, their institution, practice area, or the pharmacy profession. Their work may involve ARO initiatives, research, or advocacy that has contributed to advancements in public health for all, people-first workforces or organizations with a range of talent and experiences, and ARO awareness, advocacy, and education. Their work has had positive impacts on oncology pharmacy practice, patients, students, or colleagues in hematology/oncology pharmacy.

Award: Recipients of the award are recognized at the HOPA Annual Conference with a personalized plaque and free registration to HOPA's Annual Conference.

Eligibility: Nominees must be HOPA members in good standing. Consideration will be given to those who have demonstrated a commitment to ARO and whose work exemplifies the core values of the association and align with HOPA's ARO priorities as outlined in HOPA's ARO Statement. Current members of the HOPA Board of Directors, HOPA Recognition Committee, and HOPA staff are not eligible to either nominate or be nominated for this award. Members of the HOPA ARO Committee are eligible for nomination; however their broader contribution to ARO above and beyond their contributions to the initiatives of the committee will be considered. Self-nominations will be accepted.

The Hematology/Oncology Technician Award recognizes a technician who demonstrates excellence in his/her work and a commitment to hematology/oncology pharmacy practice in an organized health care setting.

Award: Recipients of the HOPA Hematology/Oncology Technician Award are recognized at the HOPA Annual Conference with a personalized plaque, one-year complimentary membership in HOPA, and an award check.

Eligibility: Nominees need not be HOPA members. Nominators must be HOPA members in good standing. Nominees must have at least 2 years of hematology/oncology pharmacy support experience and be currently employed in an organized health care setting. Preference will be given to those who are Certified Pharmacy Technicians (CPhT).

Current members of the HOPA Board of Directors or HOPA Recognition Committee are not eligible to nominate an individual for this award nor are they eligible to be nominated for this award.

The HOPA Leadership Award recognizes pharmacy practitioners who have distinguished themselves by demonstrating superior leadership skills when challenged by a specific opportunity, for their institution, HOPA, or the pharmacy profession that produced/culminated in a significant outcome. As a result, they will have advanced oncology pharmacy practice, or made positive changes that benefit patients, students, or colleagues in hematology/oncology pharmacy.

Award: Recipients of the award are recognized at the HOPA Annual Conference with a personalized plaque and an award check.

Eligibility: Nominees must be HOPA members in good standing. Consideration will be given to those who have demonstrated leadership during the period of eligibility, defined as the preceding year leading up to the Annual Conference. (Contributions occurring within 36 months prior to the Annual Conference that exemplify the core values of the association will be considered/evaluated.) Current members of the HOPA Board of Directors, HOPA Recognition Committee, and HOPA staff are not eligible to either nominate or be nominated for this award. Self-nominations will be accepted.

The HOPA Oncology Pharmacy Practice Literature Award recognizes an author who has written an article, other than scientific research, that contributes significantly to the betterment of the hematology/oncology pharmacy profession and describes innovations in community, hospital, or healthcare system hematology/oncology pharmacy practices published (print or electronic) by a HOPA member between October 1, 2024, and September 30, 2025.

Award: Recipients of the award will be recognized at the HOPA Annual Conference with a personalized plaque and an award check. (Winners may choose to share the award; however, no additional authors will be recognized as award recipients by HOPA.)

Eligibility: Eligible publications include published materials appearing in the primary literature (electronic or print) that are widely available of which the nominee was a primary author, lead, or senior author. For this award, oncology pharmacy practice refers to all aspects of professional practice, including administration, management, drug use control, technological services, clinical services, information processing, and new practice models. *Papers that describe scientific research are not eligible for this award.

Self-nominations are allowed. Nominees and nominator(s) must be HOPA members in good standing. Current members of the HOPA Board of Directors or HOPA Recognition Committee are not eligible to nominate an individual for this award nor are they eligible to be nominated for this award.

Note: The HOPA Recognition Committee reserves the right to change the type of Literature Award selected by the nominator to the type that more appropriately reflects the eligibility criteria for the submitted article.

The HOPA Basic Science and Clinical Research Literature Award recognizes an author who has written an important scientific article describing hematology/oncology basic science and/or translational research or clinical trials evaluating drug efficacy and/or safety published (print or electronic) by a HOPA member between October 1, 2024, and September 30, 2025.

Award: Recipients of the award will be recognized at the HOPA Annual Conference with a personalized plaque and an award check. (Winners may choose to share the award; however, no additional authors will be recognized as award recipients by HOPA.)

Eligibility: Eligible publications include published materials appearing in the primary literature (electronic or print) that are widely available of which the nominee was a primary author, lead, or senior author. Eligible publications describe research related to hematology/oncology that uses formalized testing and the scientific approach. Examples of scientific research include: cellular, genetic, and/or animal studies; studies that evaluate clinical effects and/or drug safety; and pharmacodynamic or pharmacokinetic studies of drug therapy. While both primary research and review articles will be accepted, primary articles of comparable quality may be given preference by the committee.

Self-nominations are allowed. Nominees and nominator(s) must be HOPA members in good standing. Current members of the HOPA Board of Directors or HOPA Recognition Committee are not eligible to nominate an individual for this award nor are they eligible to be nominated for this award.

Note: The HOPA Recognition Committee reserves the right to change the type of Literature Award selected by the nominator to the type that more appropriately reflects the eligibility criteria for the submitted article.

The HOPA Mentorship Award recognizes a HOPA member who has demonstrated outstanding mentorship by dedicating time, knowledge, and energy for the purposes of guiding, nurturing, and supporting mentees. Awardees who have demonstrated extraordinary contributions to supporting personal and professional development of residents, students, or colleagues in hematology/oncology pharmacy.

Award: Recipients of the award are recognized at the HOPA Annual Conference with a personalized plaque and free registration to the conference.

Eligibility: Nominees must be HOPA members in good standing. Consideration will be given to those who have demonstrated a commitment to the development of others and whose guidance exemplifies the core values of the association.

The individual should be an exemplary preceptor, professor, and/or mentor of students, residents, pharmacy technicians, and/or colleagues who has demonstrated a sustained history of commitment to mentorship. The individual should be a positive role model for pharmacists, pharmacy technicians, pharmacy residents, and/or pharmacy students.

Current members of the HOPA Board of Directors, HOPA Recognition Committee, and HOPA staff are not eligible to either nominate or be nominated for this award. Members of the Mentorship Program are eligible for nomination; however their broader contribution to HOPA above and beyond their contribution to the initiatives of the program will be considered.

Self-nominations will be accepted.

The HOPA New Practitioner Award recognizes a member early in their career who has made a notable contribution to developing or supporting clinical hematology/oncology pharmacy services.

Award: Recipients of the award are recognized at the HOPA Annual Conference with a personalized plaque and an award check.

Eligibility: Nominees for this award have been practicing for 7 or fewer years in the field hematology/oncology after the completion of their traning (PGY2 or fellowship). Nominees and nominator(s) must be HOPA members in good standing. Current members of the HOPA Board of Directors or HOPA Recognition Committee are not eligible to nominate an individual for this award nor are they eligible to be nominated for this award.

The HOPA Outstanding Clinician Award recognizes an experienced clinician who has made a demonstrated commitment to developing, supporting, and expanding hematology/oncology pharmacy services in a clinical setting. This individual has dedicated their career so far to increasing the quality and quantity of oncology pharmacists' involvement in patient care.

Award: Recipients of the award are recognized at the HOPA Annual Conference with a personalized plaque and an award check.

Eligibility: Nominees for this award have been practicing for 8 or more years in the field of hematology/oncology after the completion of their training. At least 50% of their workload is devoted to clinical practice. Nominees and nominator(s) must be HOPA members in good standing.

Recipients of the New Practitioner Award in the previous 3 years are not eligible. Current members of the HOPA Board of Directors or HOPA Recognition Committee are not eligible to nominate an individual for this award nor are they eligible to be nominated for this award.

Application requirements

• Completed nomination form*
• Letter of support*
• Copy of nominee's CV

*At least one of these two materials must be completed by the nominee's clinical supervisor/manager. The other can be submitted by a pharmacy peer, non-pharmacy clinician (i.e., physicians, nurses, physician assistants, etc.), or patient.

Supporting documents can be uploaded directly within the nomination form or emailed to HOPA staff (info@hoparx.org).

The HOPA Patient Advocacy Award recognizes a HOPA member who demonstrates leadership and collaboration while advocating for outstanding patient care. Areas for advocacy may include:

• improved patient resources
• access to care
• education or service in the legislative, organizational, or community setting

Award: Recipients of the award are recognized at the HOPA Annual Conference with a personalized plaque and an award check.

Eligibility: Nominees must be HOPA members in good standing and may submit a self-nomination or be nominated by someone within the pharmacy, oncology, hematology, or cancer community. Current members of the HOPA Board of Directors, HOPA Recognition Committee, and HOPA staff are not eligible to either nominate or be nominated for this award.

Nomination requirements

1. Completed nomination form
2. Current CV for the nominee
3. If self-nominated, you must provide a letter of reference from either a HOPA member or non-member describing your contributions to patient advocacy. This letter is in addition to the completed nomination form and should address the criteria for the award. The reference letter is available within the application to be completed by the reference and uploaded by the applicant, or an email request can be sent within the application for the reference to log in and complete it by the nomination deadline.

The HOPA Volunteer Award recognizes the time, talent, and energy of a HOPA member who contributes significant volunteer service to the organization through committee and/or task force contributions and representing HOPA at external events.

Award: Recipients of the award are recognized at the HOPA Annual Conference with a personalized plaque and an award check. The recipient will also be featured in April, to coincide with National Volunteer Week (such as the HOPA Member Update and HOPA's social media accounts).

Eligibility: Nominees must be HOPA members in good standing, be actively involved in organizational work (e.g., serving on a committee, participating in a task force, representing HOPA at external events, etc.) during the period of eligibility, defined as the preceding year leading up to the Annual Conference. (Contributions occurring within 36 months prior to the Annual Conference that exemplify the core values of the association will be considered/evaluated.) Current members of the HOPA Board of Directors, HOPA Recognition Committee, and HOPA staff are not eligible to either nominate or be nominated for this award. Self-nominations will be accepted.